Search
Searching Content indexed under Litigation, Mediation & Arbitration by Areta Kupchyk ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
FDA And Amarin Pharma Reach Milestone Settlement Allowing Off-Label Drug Promotion
A milestone Settlement Agreement was reached March 8, 2016 between the Food and Drug Administration and Amarin Pharma, Inc. that expressly allows Amarin to promote its drug product, Vascepa®, for unapproved – i.e., "off-label" – uses.
United States
31 Mar 2016
Links to Result pages
 
1